Pharbetol
- Product NDC
- 17856-0353
- 11-digit product format
- 178560353
- Labeler code
- 17856
- Product ID
- 17856-0353_36d8e8fb-3928-ffbe-e063-6394a90a5779
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Acetaminophen
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- ATLANTIC BIOLOGICALS CORP.
- Application
- M
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2007-01-09
- Substance
- ACETAMINOPHEN
- Active strength
- 325 mg/1
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded product | product | 17856-0353 | I | Inactivated by FDA | 2026-10-12 | ||
| excluded package | package | 17856-0353 | 17856-0353-3 | I | Inactivated by FDA | 2026-10-12 |
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Package NDC | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|
| 2024-05-28 21:12 UTC · source 2024-05-28 | excluded product | product | 8af77b9d5b6f… | d9bbb34c5368… | |
| 2024-05-28 21:12 UTC · source 2024-05-28 | excluded package | package | 17856-0353-1 | 8af77b9d5b6f… | d9bbb34c5368… |
| 2024-05-15 03:39 UTC · source 2024-05-14 | excluded product | product | 834df4deac94… | adcc014656a3… | |
| 2024-05-15 03:39 UTC · source 2024-05-14 | excluded package | package | 17856-0353-1 | 834df4deac94… | adcc014656a3… |
| 2024-03-11 06:39 UTC · source 2024-03-08 | excluded product | product | 1332a3947898… | d4bfe170f9cd… | |
| 2024-03-11 06:39 UTC · source 2024-03-08 | excluded package | package | 17856-0353-1 | 1332a3947898… | d4bfe170f9cd… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Pharbetol
- Brand name suffix
- Regular strength
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| ACETAMINOPHEN | 325 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 362O9ITL9D | Internal UNII lookup |
Harmonized RxCUI identifiers#
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 05a91d24-b498-4ba2-a275-68b871cf62d2 | Available on FDA.report |
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 17856-0353-1 | 2024-06-26 | C162847 | 48780-1 | 1030e365-250f-111a-e063-dadaa90a10e2 | PHARBEST IBUPROFEN Drug Facts |
| 17856-0353-1 | 2024-01-30 | C162847 | 48780-1 | 1030e365-250f-111a-e063-dadaa90a10e2 | PHARBEST IBUPROFEN Drug Facts |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 17856-0353-1 | PharbetolRegular strength | 100 in 1 BOX, UNIT-DOSE | TABLET | 100 | 3 | |
| 17856-0353-2 | PharbetolRegular strength | 1 in 1 POUCH | TABLET | 1 | 3 | |
| 17856-0353-4 | PharbetolRegular strength | 24 in 1 BOTTLE | TABLET | 24 | 3 | |
| 17856-0353-3 | PharbetolRegular strength | 28 in 1 BOTTLE | TABLET | 28 | 1 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 17856-0353 | PHARBETOL REGULAR STRENGTH (ACETAMINOPHEN) TABLET [ATLANTIC BIOLOGICALS CORP.] | 2 | Current NDC, Legacy NDC, 3 package rows | 20240627_05a91d24-b498-4ba2-a275-68b871cf62d2.zip |
| 17856-0353 | PHARBETOL REGULAR STRENGTH (ACETAMINOPHEN) TABLET [ATLANTIC BIOLOGICALS CORP.] | 1 | Current NDC, Legacy NDC, 1 package rows | 20240508_bd26081c-e81e-42e8-b3da-2813863a51df.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| MAX relief junior | ACETAMINOPHEN | ATLANTIC BIOLOGICALS CORP. | 396903dc-ae2d-4bf4-b1fd-0017b84abef9 | 2024-02-28 | Warnings | M |
| MAX relief junior | ACETAMINOPHEN | ATLANTIC BIOLOGICALS CORP. | 44730cbd-5b98-49bd-b3b8-6fecb0ccd153 | 2024-02-28 | Warnings | M |
| HYDROCORTISONE | HYDROCORTISONE ACETATE | HART Health | 779f945f-ab69-40de-8d86-ab76debc5c7c | 2024-02-16 | Warnings | M |
| First Aid and Burn | BENZALKONIUM CHLORIDE, LIDOCAINE | HART Health | f5746bba-9d7f-4691-b466-14985473bf14 | 2024-02-16 | Warnings | M |
| IBUPROFEN | IBUPROFEN | HART Health | 1c1374e1-890f-48ab-8f93-e84da9d5bf84 | 2024-01-25 | Warnings | M |
| Hand Sanitizer | ANTISEPTIC GEL | HART Health | f07daf29-d0db-4cf8-8baf-d175c2b2ef50 | 2024-01-25 | Warnings | M |
| Hydrogen Peroxide | HYDROGEN PEROXIDE | HART Health | 0346a322-8f6e-405a-8d17-8bc6ce5105a3 | 2024-01-24 | Warnings | M |
| Alcohol | ISOPROPYL ALCOHOL | NorMed | 441b915a-287f-4734-b4d9-730b3d95e04c | 2024-01-24 | Warnings | M |
| Sooth-a-Sting | BENZOCAINE | HART Health | bd7229b6-813a-4149-bfe2-fe682f270ff4 | 2024-01-18 | Warnings | M |
| First Aid | BENZALKONIUM CHLORIDE, BENZOCAINE | HART Health | a6d258ed-6d6d-42f0-9994-6c2c4c3d0f4a | 2024-01-18 | Warnings | M |
| TRIBIOTIC | BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE | HART Health | d8f175f9-f526-4c73-a171-49309ca16cb0 | 2024-01-18 | Warnings, Adverse reactions | M |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 313782 | acetaminophen 325 MG Oral Tablet | PSN | 05a91d24-b498-4ba2-a275-68b871cf62d2 | 3 |
| 1298830 | Pharbetol Regular Strength 325 MG Oral Tablet | PSN | 05a91d24-b498-4ba2-a275-68b871cf62d2 | 3 |
| 1298830 | acetaminophen 325 MG Oral Tablet [Pharbetol] | SBD | 05a91d24-b498-4ba2-a275-68b871cf62d2 | 3 |
| 313782 | acetaminophen 325 MG Oral Tablet | SCD | 05a91d24-b498-4ba2-a275-68b871cf62d2 | 3 |
| 313782 | APAP 325 MG Oral Tablet | SY | 05a91d24-b498-4ba2-a275-68b871cf62d2 | 3 |
| 1298830 | APAP 325 MG Oral Tablet [Pharbetol] | SY | 05a91d24-b498-4ba2-a275-68b871cf62d2 | 3 |
| 1298830 | Pharbetol 325 MG Oral Tablet | SY | 05a91d24-b498-4ba2-a275-68b871cf62d2 | 3 |
| 313782 | acetaminophen 325 MG Oral Tablet | PSN | bd26081c-e81e-42e8-b3da-2813863a51df | 1 |
| 1298830 | Pharbetol Regular Strength 325 MG Oral Tablet | PSN | bd26081c-e81e-42e8-b3da-2813863a51df | 1 |
| 1298830 | acetaminophen 325 MG Oral Tablet [Pharbetol] | SBD | bd26081c-e81e-42e8-b3da-2813863a51df | 1 |
| 313782 | acetaminophen 325 MG Oral Tablet | SCD | bd26081c-e81e-42e8-b3da-2813863a51df | 1 |
| 313782 | APAP 325 MG Oral Tablet | SY | bd26081c-e81e-42e8-b3da-2813863a51df | 1 |
| 1298830 | APAP 325 MG Oral Tablet [Pharbetol] | SY | bd26081c-e81e-42e8-b3da-2813863a51df | 1 |
| 1298830 | Pharbetol 325 MG Oral Tablet | SY | bd26081c-e81e-42e8-b3da-2813863a51df | 1 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 17856-0353-1 | 17856035301 | 100 POUCH in 1 BOX, UNIT-DOSE (17856-0353-1) / 1 TABLET in 1 POUCH (17856-0353-2) | 100 pouch | 2024-06-26 | 0000-00-00 | No | No | Current |
| 17856-0353-2 | 17856035302 | 1 in 1 POUCH | Historical | |||||
| 17856-0353-3 | 17856035303 | 28 in 1 BOTTLE | Historical | |||||
| 17856-0353-4 | 17856035304 | 24 TABLET in 1 BOTTLE (17856-0353-4) | 24 tablet | 2024-06-26 | No | No | Current |